Jazz Pharmaceuticals Welcomes Philip Johnson in the Role of Executive VP and CFO
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announces the appointment of Philip Johnson as Executive Vice President and Chief Financial Officer, effective March 1, 2024. Johnson succeeds Renée Galá, who assumed the role of President and Chief Operating Officer in October 2023.
Jazz Pharmaceuticals, headquartered in Dublin, Ireland, operates globally with a workforce spanning nearly 75 countries dedicated to serving patients worldwide.
In his new capacity, Johnson will lead financial reporting, accounting, tax, treasury, risk management, financial planning and analysis, information services, and facilities, along with managing investor relations and corporate development functions.
Bruce Cozadd, Chairman and CEO of Jazz Pharmaceuticals, expresses confidence in Johnson’s strategic prowess and leadership, emphasizing his alignment with Jazz’s growth strategy and commitment to enhancing shareholder value.
Johnson, in his statement, acknowledges Jazz’s esteemed reputation, robust financial standing, and promising growth prospects. He expresses enthusiasm for contributing his cross-functional expertise to drive Jazz’s mission of addressing unmet patient needs worldwide.
Johnson’s extensive career includes nearly three decades at Eli Lilly and Company, where he held various senior finance roles globally. Notably, he served as Group Vice President of Finance, overseeing treasury and investor relations. Johnson also led Lilly’s investor relations efforts for over a decade, fostering strong relationships with the investment community.
Have you read?
The world’s largest economies in 2023.
Ranked: Safest Countries in the World, 2023.
Countries With the Most Female Billionaires, 2023.
Economy Rankings: Largest countries by GDP, 2023.
The Global Passport Index: The World’s Most Powerful Passports.
Richest countries in the world by GDP per capita in 2023.
